• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Managed Care Cast Presents: Stakeholders Summit—Biosimilars in Inflammatory Diseases, Part 2

Commentary
Podcast

In part 2 of this 2-part podcast, a panel of experts discusses challenges with biosimilar uptake, interchangeability studies, patient and provider education.

Today we are bringing you part 2 of a 2-part sponsored podcast series discussing the use of biosimilars in inflammatory diseases. The discussion was moderated by Ryan Haumschild, PharmD, director of Pharmacy Services at Emory Healthcare and Winship Cancer Institute.

The conversation for today’s podcast includes challenges with biosimilar uptake, interchangeability studies, patient and provider education.

Listen above or through one of these podcast services:

iTunes
TuneIn
Stitcher
Spotify

Related Videos
Eneline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA
Related Content
Top 5 Most-Listened to Podcast Episodes of 2021

Top 5 Most Listened to Podcast Episodes of 2021

December 29th 2021
Article

The top 5 most-listened to podcast episodes of 2021 on AJMC.com involved experts from a variety of industries that talked about some of the hot-button issues in kidney care, migraine management, and Medicare.

Read More

managed care cast logo

Operationalizing Bispecifics in Multiple Myeloma

November 27th 2024
Podcast

Tyler Sandahl, PharmD, of Mayo Clinic, and Michael Byrne, DO, of Tennessee Oncology, discuss practical advice for bringing bispecifics to the community.

Listen

COPD Stakeholder Summit—Individualizing Treatment and Improving Outcomes, Part 1

COPD Stakeholder Summit—Individualizing Treatment and Improving Outcomes, Part 1

March 11th 2021
Article

In part 1 of the COPD Stakeholder Summit, a panel of experts about the burden of COPD, available treatments, and more.

Read More

© 2024 MJH Life Sciences
AJMC®
All rights reserved.